NEO-201 is a humanized antibody targeting CEACAM6/CD66c with antitumor activity that binds to tumor-associated variants of carcinoembryonic antigen-associated cellular adhesion molecule (CEACAM)-5 and CEACAM-6, and can be used in the study of breast cancer.
PTA001_A4 (Anti-CDH17/Cadherin-17 Antibody) is a humanized antibody targeting CDH17/Cadherin-17 with potential anti-tumor activity, inhibits the growth of tumor cells, and can be used for cancer research.